Medicare Advantage, also known as Medicare Part C, is a program run by private insurance companies that offers a private-sector alternative to traditional Original Medicare (Parts A and B). This program has become increasingly popular, with enrollment surpassing half of all Medicare beneficiaries. While Medicare Advantage plans must cover all hospital and medical benefits at least as comprehensively as Original Medicare, they often include additional benefits such as prescription drug coverage, dental, vision, and hearing aids.
On January 27, 2026, UnitedHealth Group’s stock plummeted 19.57% following disappointing Q4 2025 earnings and a policy announcement from the Trump administration proposing flat government Medicare payment rates in 2027. This drastic drop, erasing roughly $80 billion in market capitalization, highlighted the pressures faced by private insurers in the Medicare Advantage space.
The Centers for Medicare & Medicaid Services (CMS) recently released their Advance Notice for Calendar Year 2027 Medicare Advantage capitation rates, proposing a net average payment increase of just 0.09%. This proposal, far below the 2-3% growth needed to offset inflation and cost trends, has sent shockwaves through the healthcare industry. UnitedHealth Group, along with other insurers like CVS and Humana, are feeling the impact of this unexpected adjustment.
A recent investigation by the Wall Street Journal revealed that Medicare Advantage insurers, including UnitedHealth Group, have been adding potentially questionable or unsupported diagnoses to patient records to generate additional federal payments. This practice has led to billions in extra payments over the years, sparking concerns about overpayment and the sustainability of the program.
The proposed payment increase of 0.09% could have significant implications for Medicare Advantage beneficiaries. Plans may be forced to slash benefits, increase premiums, or exit markets, leading to narrower networks, more prior authorization denials for procedures, and reduced extras like dental and vision coverage. Patients may experience delays in care and worsened outcomes as a result of these changes.
From a surgeon’s perspective, the challenges of dealing with Medicare Advantage plans, particularly in obtaining prior authorizations for necessary procedures, are expected to persist. With the proposed payment increase falling below expectations, patients may face even more difficulties accessing timely surgical care.
In conclusion, the recent developments in the Medicare Advantage space have far-reaching implications for both insurers and patients. As the debate over payment rates and overpayment continues, it is crucial to consider the impact on the quality and accessibility of healthcare for Medicare Advantage beneficiaries.
